![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2016
Anzahl der Publikationen: 5
2016
Sipol, A.; Grunewald, T. G. P.; Schmaeh, J.; Boer, M. L. den; Rubío, R. Alba; Baldauf, M.; Wernicke, C.; Horstmann, M.; Cario, G.; Richter, G. und Burdach, S.
(2016):
MondoA mediates in vivo aggressiveness of common ALL by induction of HIF1 alpha.
In: European Journal of Cancer, Bd. 69:
S50-S50
Thiel, U.; Blaeschke, F.; Richter, G. und Burdach, S.
(2016):
Human HLA-A*02:01/CHM1+allo-restricted T cell receptor-transgenic CD8+T cells specifically inhibit Ewing sarcoma growth in vitro and in vivo.
In: European Journal of Cancer, Bd. 69:
S51-S51
Schirmer, D.; Grünewald, T.; Klar, R.; Schmidt, O.; Wohlleber, D.; Alba Rubío, R.; Uckert, W.; Thiel, U.; Protzer, U.; Busch, D.; Krackhardt, A.; Burdach, S. und Richter, G.
(2016):
Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize and kill tumor associated antigen STEAP1+tumour cells in vivo.
In: European Journal of Cancer, Bd. 69:
S93-S93
Weidenbusch, B.; Richter, G.; Teichert-von Lüttichau, I.; Gall, K.; Alter, M.; Dirksen, U.; Lindner, L.; Mansmann, Ulrich und Burdach, S.
(2016):
Transcriptome Based Individualized Therapy Of Refractory Pediatric Bone and Soft Tissue Sarcomas: Feasibility, Tolerability and Efficacy.
In: Oncology Research and Treatment, Bd. 39: S. 127
Thiel, U.; Blaeschke, F.; Richter, G.; Grünewald, T.; Busch, D.; Alba Rubio, R.; Thiede, M.; Kirschner, A.; Pirson, S.; Mall, S.; Klar, R.; Leisegang, M.; Krackhardt, A.; Uckert, W.; Riddell, S. und Burdach, S.
(2016):
Human T Cell Receptor transgenic CD8(+) T cells specifically kill HLA-A*0201/CHM1(+) Ewing Sarcoma Lines in vitro and in a preclinical Mouse Model.
In: Oncology Research and Treatment, Bd. 39: S. 147